CLEVELAND, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Abeona’s ...
Based on these positive data, Adaptimmune plans to initiate a rolling Biologics License Application (BLA) submission for lete-cel for the treatment of advanced or metastatic synovial sarcoma and ...
we CUT OPEN a copic wide marker to see what was inside! The result was pretty amazing and I really did not expect to see what I saw! it was really cool to see what was inside of the copic marker!
The company is progressing with its trem-cel therapy, having now dosed 25 patients, including six at the highest Mylotarg maintenance dose. This progress is seen as a step closer to demonstrating ...
Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS requirement, based on the FELIX trial's positive outcomes. The FELIX trial reported a 63% complete remission rate ...
consider what our pancreas remembers about the pattern of our past meals to maintain healthy levels of blood glucose or consider what a cancer cell remembers about the pattern of chemotherapy." ...
Equecabtagene autoleucel showed high efficacy in relapsed/refractory multiple myeloma, with a 96% overall response rate and 42.6% complete response rate at three months. Minimal residual disease ...
While still preliminary, the benign neurotoxicity assessment for the therapy, called anito-cel, suggests it could be a safer option for patients with multiple myeloma compared to Carvytki ...
Arcellx and Gilead presented data from two trials of their drug, called anitocabtagene autoleucel or anito-cel. They included a Phase 2 study that the companies hope supports regulatory approval in ...
(PNA photo by Joan Bondoc) MANILA – The Commission on Elections (Comelec) has approved the 15 percent shading threshold on the ballot in the May 2025 National and Local Elections (NLE), the lowest ...
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer ...